Pfizer Wins New Pediatric Approval for Atopic Dermatitis Ointment Eucrisa

The U.S. Food and Drug Administration (FDA) greenlit a new pediatric approval for Pfizer’s Eucrisa ointment in the treatment of mild-to-moderate atopic dermatitis, an inflammatory skin disease that impacts a large number of pre-adolescent children.